 Hayla Sluss
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 11 | 2011 | 244 | 2.720 |
Why?
| | Cell Cycle Proteins | 5 | 2011 | 299 | 0.990 |
Why?
| | Glucose | 2 | 2015 | 312 | 0.910 |
Why?
| | Protein-Serine-Threonine Kinases | 3 | 2011 | 320 | 0.820 |
Why?
| | Serine | 3 | 2010 | 62 | 0.780 |
Why?
| | Apoptosis | 5 | 2010 | 844 | 0.740 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 35 | 0.620 |
Why?
| | Prediabetic State | 1 | 2015 | 26 | 0.620 |
Why?
| | Insulin Resistance | 2 | 2015 | 301 | 0.600 |
Why?
| | Fibroblasts | 8 | 2015 | 278 | 0.560 |
Why?
| | Tumor Suppressor Proteins | 2 | 2011 | 169 | 0.540 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2010 | 172 | 0.530 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2011 | 329 | 0.510 |
Why?
| | Nuclear Localization Signals | 1 | 2010 | 14 | 0.470 |
Why?
| | Neural Tube Defects | 1 | 2010 | 9 | 0.470 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 425 | 0.450 |
Why?
| | Mice | 13 | 2015 | 7193 | 0.440 |
Why?
| | Mice, Inbred C57BL | 7 | 2015 | 2222 | 0.440 |
Why?
| | DNA-Binding Proteins | 3 | 2011 | 989 | 0.440 |
Why?
| | Lymphoma, B-Cell | 1 | 2010 | 46 | 0.440 |
Why?
| | Signal Transduction | 6 | 2015 | 2231 | 0.430 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2010 | 77 | 0.430 |
Why?
| | Homeostasis | 1 | 2010 | 218 | 0.410 |
Why?
| | Phosphorylation | 5 | 2011 | 657 | 0.400 |
Why?
| | DNA Fragmentation | 1 | 2006 | 31 | 0.350 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2006 | 108 | 0.350 |
Why?
| | Animals | 13 | 2015 | 14303 | 0.320 |
Why?
| | Nuclear Proteins | 2 | 2010 | 683 | 0.290 |
Why?
| | Histones | 1 | 2006 | 331 | 0.280 |
Why?
| | Germ-Line Mutation | 2 | 2011 | 34 | 0.220 |
Why?
| | Animals, Genetically Modified | 2 | 2010 | 219 | 0.220 |
Why?
| | Antioxidants | 2 | 2010 | 133 | 0.210 |
Why?
| | Insulin | 2 | 2015 | 558 | 0.210 |
Why?
| | Mice, Knockout | 4 | 2015 | 1555 | 0.200 |
Why?
| | Cells, Cultured | 2 | 2015 | 1751 | 0.200 |
Why?
| | Mutation | 3 | 2011 | 1722 | 0.190 |
Why?
| | Cell Proliferation | 2 | 2011 | 661 | 0.190 |
Why?
| | Cell Aging | 2 | 2007 | 74 | 0.180 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2015 | 4 | 0.160 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 37 | 0.150 |
Why?
| | Leptin | 1 | 2015 | 50 | 0.150 |
Why?
| | Glucose Intolerance | 1 | 2015 | 61 | 0.150 |
Why?
| | Interleukin-6 | 1 | 2015 | 215 | 0.140 |
Why?
| | Dietary Fats | 1 | 2015 | 202 | 0.140 |
Why?
| | Reactive Oxygen Species | 2 | 2010 | 141 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase 8 | 2 | 2010 | 52 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 459 | 0.130 |
Why?
| | Proto-Oncogene Proteins | 2 | 2004 | 263 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 444 | 0.130 |
Why?
| | Cell Division | 3 | 2007 | 410 | 0.120 |
Why?
| | Genes, Lethal | 1 | 2010 | 32 | 0.120 |
Why?
| | Ataxia Telangiectasia | 1 | 2010 | 10 | 0.120 |
Why?
| | Genes, ras | 1 | 2010 | 22 | 0.120 |
Why?
| | Homozygote | 1 | 2010 | 99 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2010 | 59 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2010 | 31 | 0.110 |
Why?
| | Models, Genetic | 1 | 2011 | 225 | 0.110 |
Why?
| | Ultraviolet Rays | 1 | 2010 | 103 | 0.110 |
Why?
| | Male | 4 | 2015 | 16965 | 0.110 |
Why?
| | Embryo, Mammalian | 2 | 2007 | 119 | 0.110 |
Why?
| | Oncogenes | 1 | 2010 | 37 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 115 | 0.110 |
Why?
| | Immunoglobulin Class Switching | 1 | 2010 | 80 | 0.110 |
Why?
| | Cell Survival | 1 | 2010 | 440 | 0.100 |
Why?
| | Cell Cycle | 1 | 2010 | 325 | 0.100 |
Why?
| | Up-Regulation | 1 | 2010 | 305 | 0.100 |
Why?
| | Immunoglobulin G | 1 | 2010 | 327 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2011 | 899 | 0.100 |
Why?
| | DNA Damage | 1 | 2010 | 260 | 0.090 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2007 | 29 | 0.090 |
Why?
| | Obesity | 1 | 2015 | 867 | 0.090 |
Why?
| | Genes, p53 | 2 | 2007 | 40 | 0.090 |
Why?
| | Genotype | 1 | 2007 | 463 | 0.090 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 1468 | 0.090 |
Why?
| | Proteins | 1 | 2010 | 571 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2010 | 684 | 0.080 |
Why?
| | Phosphotransferases | 1 | 2004 | 14 | 0.070 |
Why?
| | Cyclins | 1 | 2004 | 40 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2004 | 40 | 0.070 |
Why?
| | Female | 4 | 2011 | 18694 | 0.070 |
Why?
| | Acetylation | 1 | 2003 | 101 | 0.070 |
Why?
| | ras Proteins | 1 | 2003 | 61 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 304 | 0.070 |
Why?
| | Gene Targeting | 1 | 2003 | 70 | 0.070 |
Why?
| | Humans | 3 | 2011 | 33638 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 154 | 0.060 |
Why?
| | Alleles | 1 | 2003 | 303 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2003 | 193 | 0.060 |
Why?
| | Neoplasms | 1 | 2007 | 601 | 0.060 |
Why?
| | Mice, SCID | 1 | 2003 | 425 | 0.060 |
Why?
| | Protein Processing, Post-Translational | 1 | 2003 | 174 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 676 | 0.060 |
Why?
| | Aging | 1 | 2003 | 518 | 0.050 |
Why?
| | Time Factors | 1 | 2004 | 2558 | 0.050 |
Why?
| | Mammary Glands, Animal | 1 | 2010 | 61 | 0.030 |
Why?
| | Cell Separation | 1 | 2010 | 133 | 0.030 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 58 | 0.030 |
Why?
| | Survival Analysis | 1 | 2010 | 373 | 0.030 |
Why?
| | Cytidine Deaminase | 1 | 2010 | 74 | 0.030 |
Why?
| | Blotting, Western | 1 | 2010 | 523 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2010 | 797 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 505 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2010 | 591 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2007 | 21 | 0.020 |
Why?
| | Protein Kinases | 1 | 2007 | 136 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 438 | 0.020 |
Why?
| | Kinetics | 1 | 2007 | 701 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2010 | 1166 | 0.020 |
Why?
| | E2F Transcription Factors | 1 | 2004 | 16 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 45 | 0.020 |
Why?
| | Neoplasms, Experimental | 1 | 2003 | 61 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2004 | 112 | 0.020 |
Why?
| | Mice, Nude | 1 | 2003 | 200 | 0.020 |
Why?
| | Cell Line | 1 | 2003 | 1729 | 0.010 |
Why?
| | Transcription Factors | 1 | 2004 | 1170 | 0.010 |
Why?
|
|
Sluss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|